DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 2750664
» See Plans and Pricing
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2750664
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 3, 2032 | Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium |
Start Trial | Aug 29, 2032 | Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium |
Start Trial | Aug 29, 2032 | Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |